Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Pediatric Oncology
What is the optimal salvage therapy for a patient with a relapsed primary mediastinal yolk sac tumor with brain metastases?
Optimal salvage chemotherapy?
Role/type of transplant?
Role for RT?
Role for surgery/neurosurgery?
Related Questions
How do you decide on lung constraints for SBRT after whole lung radiation for persistent nodules?
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
What is the optimal timing of salvage radiotherapy for recurrent metastatic neuroblastoma and what is the preferred dose and fractionation?
In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?
How would you treat a patient with isolated CNS relapse of seminoma?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
How would you manage an enlarging brain metastasis that has progressed in size three months after radiosurgery?
With the recent BART, trial how would you manage a positive ureter margin that is now part of the urostomy?
How do you counsel patients/families whose goals of care are clearly aligned with a comfort-focused, end-of-life approach, but who are hesitant to formally enroll in hospice?